Gibson Christopher

CIK 00018563692 companiesSALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001856369

Recent Transactions

50 trades

Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-06-05$3.62/sh−40,000→ 883,735 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-06-05+40,000→ 923,735 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-06-05−40,000→ 4,263,334 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2026-06-03+74,497→ 74,497 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-05-22−40,000→ 4,303,334 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-05-22$3.08/sh−40,000→ 883,735 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-05-22+40,000→ 923,735 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-05-15$3.04/sh−22,821→ 883,735 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-05-07−20,000→ 906,556 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-05-07$3.37/sh−40,000→ 926,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-05-07−60,000→ 4,343,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-05-07+60,000→ 966,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-04-22−40,000→ 4,403,334 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-04-22$3.61/sh−40,000→ 906,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-04-22+40,000→ 946,556 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2026-04-08+77,842→ 77,842 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2026-04-08+57,473→ 111,386 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-04-07−40,000→ 4,443,334 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-04-07$3.10/sh−40,000→ 906,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-04-07+40,000→ 946,556 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-03-23$3.25/sh−40,000→ 906,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-03-23+40,000→ 946,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-03-23−40,000→ 4,483,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-03-09+20,000→ 926,556 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-03-09−20,000→ 906,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-03-09−20,000→ 4,523,334 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Stock Option (right to buy)
2026-03-03+73,087→ 73,087 total
Award
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.$PACB
Common Stock
2026-03-03+53,913→ 53,913 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-19$3.46/sh−40,000→ 906,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-19+40,000→ 946,556 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-02-19−40,000→ 4,543,334 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-17$3.49/sh−27,265→ 906,556 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-06+30,346→ 944,185 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-06$3.56/sh−10,364→ 933,821 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-02-04−40,000→ 4,583,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-04+40,000→ 953,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-02-04$4.12/sh−40,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-20+40,000→ 953,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-20$4.47/sh−40,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-01-20−40,000→ 4,623,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2026-01-05−60,000→ 4,663,334 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-05$4.25/sh−40,000→ 933,839 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-05−20,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-01-05+60,000→ 973,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-12-19−40,000→ 4,723,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-19+40,000→ 953,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-19$4.50/sh−40,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04+60,000→ 973,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04$4.63/sh−40,000→ 933,839 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04−20,000→ 913,839 total

Companies

Recent Filings

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov